FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068474 [Registered on: 06/06/2024] Trial Registered Prospectively
Last Modified On: 18/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A study on effectiveness of varma drug and varmam for lumbar spondylosis. 
Scientific Title of Study   An open clinical trial to evaluate the therapeutic efficacy of Varma Kanji (Internal) and Lagu Vishamutti Thylam (External) with Varmam therapy in the management of Thandagavatham (Lumbar Spondylosis) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR V P Gaayathri 
Designation  Postgraduate Scholar 
Affiliation  National Institute of Siddha 
Address  Department of varmam maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai.

Kancheepuram
TAMIL NADU
600047
India 
Phone  9360975192  
Fax  22381314  
Email  gaayathripruthvi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR D Periyasami 
Designation  Associate Professor HOD (i/c) 
Affiliation  National Institute of Siddha 
Address  Department of varmam maruthuvam National Institute of Siddha, Tambaram Sanatorium, Chennai.I

Kancheepuram
TAMIL NADU
600047
India 
Phone  7358481734  
Fax  22381314  
Email  sami2011nis@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR D Periyasami 
Designation  Associate Professor HOD (i/c) 
Affiliation  National Institute of Siddha 
Address  Department of varmam maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai.

Kancheepuram
TAMIL NADU
600047
India 
Phone  7358481734  
Fax  22381314  
Email  sami2011nis@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Siddha, Tambaram Sanatorium, Chennai. Pincode : 600047 Tamilnadu, India. 
 
Primary Sponsor  
Name  National Institute of Siddha 
Address  National Institute of Siddha, Tambaram Sanatorium, Chennai. Pincode : 600047 Tamilnadu, India. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR V P Gaayathri  Ayothidoss Pandithar Hospital  OPD No - 15 Department of varmam maruthuvam National Institute of Siddha Tambaram Sanatorium Chennai.
Kancheepuram
TAMIL NADU 
9360975192
22381314
gaayathripruthvi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Ethics Committee, National Institute of Siddha  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M478||Other spondylosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  Varma Kanji (Internal) Lagu vishamutti thylam (External) Varmam therapy  Internal - 60ml once a day for 48 DAYS External - 50ml Applied in low back region Varmam therapy - Once in a week 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Age : 18 - 60 years
2.Sex: Male, Female and Transgender
3.Score between 40 - 80 % in ABERDEEN LOW BACK PAIN SCALE
4.Patients willing to give radiological investigation and provide blood sample for lab investigation
5.Patient willing to sign Informed Consent 
 
ExclusionCriteria 
Details  1.Ankylosing spondylitis
2.K/C/o Trauma
3.Spondylolisthesis
4.Vertebral fracture
5.Tumour in Lumbar Vertebra
6.K/C/o TB
7.K/C/o Disc Prolapse 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Mean reduction in pain, numbness & restriction of movements of Thandagavatham patients with trial medicines  18 months 
 
Secondary Outcome  
Outcome  TimePoints 
Aberdeen low back pain scale score reduced to 20%  Screening - 6 months
Patient enrollment - 6 Months
Preparation of trial drug - 2 Months
Data analysis - 1 month
Follow up - 2 Months 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   INTRODUCTION : Lumbar spondylosis is a chronic, noninflammatory disease caused by degeneration of lumbar disc and/or facet joints. It is common and worsens with age. In lumbar spondylosis, there is narrowing of the space between the vertebrae, causing a variety of health problems ranging from back pain to neurological issues. Pain or tingling symptoms that extend outward to the hip or down the leg can result from compression or inflammation of nerves, a condition referred to as lumbar radiculopathy. Nowadays, Low back pain is common among people who have sedentary lifestyle, obese, having job related risk factors that require heavy weight lifting, travelling to distant places or maintaining a poor sitting posture. The pooled point, annual, and lifetime prevalence of LBP in India was 48% (95% CI 40-56%); 51% (95% CI 45-58%), and 66%(95%CI 56-75%), respectively. The pooled prevalence rates were highest among females, therural population, and among elementary workers. The point, annual, and lifetime prevalence rates of LBP in the Indian population is higher compared to global and other ethnic populations. MATERIALS AND METHODS : A total of 30 patients within the age limit of 18 - 60 years willing to participate in the study by signing the consent form will be enrolled in the study. Both male and female patients will be enrolled. RESULTS AND DISCUSSION : Reduction of clinical symptoms of lumbar spondylosis through Aberdeen low back pain scale and the results will be statistically analysed. 
Close